Browsing: News

Singapore’s OPTIMUM trial, a telemedicine study by SingHealth Polyclinics in collaboration with the MOH Office for Healthcare Transformation, empowered diabetes patients with tools for self-care and health monitoring. With promising results, this trial could pave the way for a national rollout in diabetes management.

FDA has banned oral phenylephrine after finding it ineffective for nasal congestion. This decision affects well-known cold medicines and raises questions in Singapore, where 14 products with this ingredient remain approved. The Health Sciences Authority is reviewing the issue.

Flu shots are now available at selected Guardian, Unity, and Watsons pharmacies in Singapore in a new MOH trial to increase vaccination rates. Open to individuals 18 and above, these community locations aim to make flu vaccines more accessible for seniors and those at risk, supporting Singapore’s preventive care goals.

“Doctors and nurses from Singapore National Eye Centre recently travelled to Laos, where they screened more than 500 patients and performed 150 free cataract surgeries. This mission not only restored vision to underserved patients but also addressed long-term eye care needs in Laos through training and collaboration as a WHO Collaborating Centre.

As myopia rates soar, especially across Asia-Pacific, the 4th APMMS event spotlighted advanced solutions like CooperVision’s MiSight® 1 day lenses and multi-stakeholder collaborations. Experts and attendees emphasized the need for early intervention, reshaping myopia management to prioritise disease prevention.

HSA has banned “Q-nic Care Whitening Underarm Cream,” citing dangerous mercury and steroid levels. The authority urges users to stop immediately and warns about potential skin and health risks. Consumers are advised to purchase health products only from reputable sources to avoid unsafe ingredients.